Multiple Assemblies exist for SMTL entry 6asp
Structure of Grp94 with methyl 3-chloro-2-(2-(1-(2-ethoxybenzyl)-1 H-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate, a Grp94-selective inhibitor and promising therapeutic lead for treating myocilin-associated glaucoma;
X-RAY DIFFRACTION
2.70 Å
| |
|